Article

Similarities Among Human, Dog Mammary Tumors May Boost Cancer Research

Could household pets be the key to treating breast carcinoma?

Dogs are more than just a man’s best friend. They may actually play an important role in breast carcinoma research.

Scientists have long known the similarities between breast carcinoma in canines and humans. The tumor’s ability to reprogram healthy cells within the tumor environment to support cancer cell growth is an essential role in human breast carcinoma, but it was unknown if this mechanism also occurred in dogs.

In a study published in the International Journal of Molecular Sciences, investigators set out to answer this question.

They gained access to the tissue archive of the Institute of Veterinary Pathology located at the Animal Hospital, and used molecular biology and immunohistological methods to analyze the surrounding tissue of canine mammary tumors.

“With the permission of our patient’s owners, we conduct pathological tests to better understand diseases,” said Alexandra Malbon, animal pathologist. “In the process, we archive samples of various organs and tissues as these samples can be of great value to answer future research questions.”

By harnessing the archived canine mammary tumor samples, the investigators could confirm that some cells in the tumors vicinity have the same cancer-promoting behavior as those in humans.

“Simply speaking, the tumor enslaves its environment: it forces the surrounding cells to work for its benefit,” said investigator Enni Markkanen.

Although lab rats and mice are commonly used in research, the mammary tumors of canines have significantly higher similarities to breast carcinoma in humans. But investigators noted that this does not mean dogs will become the newest cancer research test subjects.

“We don’t view our dog patients as test subjects for cancer research,” Markkanen said. “But they can help us to better understand breast carcinoma in both dogs and humans and fight it more effectively.”

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards